Outlook Therapeutics Long Term Deferred Charges (Quarterly) Analysis

Outlook Therapeutics, Inc. (OTLK)

0.4131 -0.02 (-4.95%) USD | NASDAQ | Feb 20, 16:00

0.41 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for OTLK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Ironwood Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	--
Neogen Corp.	--
CorMedix, Inc.	--
ACADIA Pharmaceuticals, Inc.	--